Emerging Markets to Encounter Perfect Storm Driven by Global Pharma Interests?

This morning, The Financial Express is running a front page story entitled ‘Generics Gateway ,’  

Emerging Markets to Save Sanofi-Aventis from Urgent Merger Says CEO – Yet More EML Required!

The French newspaper Le Monde conducted an extensive interview with Sanofi-Aventis Chief Executive Chris Viehbacher about the drug company’s economic survival and whether or not a mega-merger is in order to achieve financial stability.  The whole interview isn’t yet available, but in this Dow Jones report about an advance copy, six specific things  are [...]

India’s Booming Emerging Medical Device Market and the GS1 Connection: GS1 Compliant EML

Here’s a summary of recent research showing the current and future expected growth of the medical device market in India. It features plenty of stats, all upward trending and at a good velocity, but it was this statement that interested me the most: The medical devices and equipments market is poised for phenomenal growth due [...]

Expansion in Emerging Markets is One of Three Key Abbott Strategies – That Means More Emergent Markets Labeling and GS1 Compliance

In a news release this morning, Abbott announced  

Do You Have an ‘Emerging Markets’ Department? Google Does.

Thanks to this short blurb in the Warsaw Business Journal, I discovered that Google is apparently so interested in emerging markets that they have a department dedicated to it and have appointed a Managing Director to oversee it. He is Mohammad Gawdat and you can read more about him and his positions on various things here [...]

Emerging Market Demand for Medical Imaging Products Helps Lift Philips Profit

This story from SmartMoney says that analysts had expected Royal Philips Electronics to post a third quarter loss  of 44.7 million euros. Instead, they posted a quarterly net income of 174 million euros.  

In Emerging Markets, Big Pharma Pursuing ‘Branded Generics’ Strategy — Still Means GS1 Barcodes On Market Compliant Labels

In this article, entitled “Major pharmaceutical companies see generics as a bridge to the future,” writer Clay Boswell first provides a review of all the major acquisitions, mergers and joint marketing agreements by large pharmaceutical companies over the past couple of years.  

Emerging Markets Show Operating Margin Advantages for the Past 15 Years — But Only If You Support Countries’ GS1 Labeling Requirements

There are two charts in this analysis of emerging market opportunities written by John Derrick, Director of Research at US Global Investors. One of them, the first one, predicts the growth rates of emerging and developed markets. It reinforces what most already know. But Mr. Derrick’s analysis of why these returns are apt to continue being [...]

Emerging Markets a Key to Unilever’s Interest in Sara Lee Unit

Are you familiar with the tagline “Nobody doesn’t like Sara Lee?” Well, that apparently goes for Unilever.  

Emerging Markets in Asia to Grow 3x Faster than Others, says IMF — Does That Mean 3x More GS1 Compliant Labeling?

Twice a year the International Monetary Fund (IMF) releases its World Economic Outlook. The most recent forecast came out yesterday and it has some important predictions for  

‘Emerging Markets’ Label No Longer Applicable Says Financial Expert – But GS1 Labeling Is Still Very Applicable

In an online story from the UK’s Financial Times, writer Marko Dimitrijevic says this: The term emerging markets is obsolete. They represent half of the world’s economy; their financial markets are large and liquid, with volatility, corporate governance and government policies very similar to those of developed markets. The traditional distinctions between emerging and developed markets, once [...]

To Expand Emerging Market Presence Abbott Labs to Buy Belgium Pharma Business for $6.6 Billion

This news came over the wire via the Associated Press (AP) at 3:33am this morning:

GS1 Importance in Emerging Markets: Brazil And GS1 Standards for Labeling

Brazil is the “B” in the shorthand for emerging markets sometimes lumped together as BRIC. Quite often here we’ve been covered news for two simultaneous points: emerging markets offer tremendous growth opportunities during this period of economic malaise in developed countries and, two, these emerging markets are making important contributions to the adoption and enforcement [...]

Emerging Markets the New ‘Friendly Skies’ Says Airbus COO

Previously here we commented on the bright future for focuing on emerging markets (and the requisite emerging markets label requirements, largely consisting of . . . GS1 compliance).  

Emerging Markets One Key to the ‘New’ Merck – All of Them Require GS1 Compliance

You probably know that Merck & Co., Inc. and Schering-Plough are merging. But as of today, we now know more about the direction of the combined entities. According to Richard T. Clark, who is chairman, president and chief executive officer of the ‘new’ Merck, the company will look at three key areas for growth as [...]

Emerging Markets Drive Globalization, Driven by Recession, says BCG Partner – More Markets Mean More GS1 Compliance

Harold L. Sirkin is a Chicago-based senior partner of The Boston Consulting Group and author, with James W. Hemerling and Arindam K. Bhattacharya, of GLOBALITY: Competing with Everyone from Everywhere for Everything.
In a recent BusinessWeek  viewpoint he summarized why he thinks history will show that these current economic times spurred a tremendous era of globalization,  

Emerging Markets are Key to California Semiconductor Firm’s Growth Strategy And That Means GS1 Labeling

A company called Amalfi Semiconductor, which is based in Los Gatos, California,

Cadbury’s Emerging Market Strengths Driving Kraft’s Acquisition Interest

The headline on this Wall Street Journal article not only says it all, but validates the emerging markets focus we’ve been featuring here for months.  

New Emerging Markets Pharma Analysis Report Available – And Every Market Requires GS1 Labeling

This news crossed Business Wire about an hour ago:
The emerging markets are luring a growing number of pharma companies looking to compensate for the diminishing revenues in developed markets. Latin America and Central and Eastern Europe (CEE) are showing strong growth rates, proving to be lucrative targets for firms aiming to expand their foothold, initially [...]

DuPont’s Emerging Markets Strategy Pivotal to Growth – More GS1 Labeling

Viet Nam News may be a rather unusual source of information, but featured here in this article is